Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
Phase 1 Completed
58 enrolled 17 charts
Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in Sicily
Completed
4,622 enrolled
Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Phase 1/2 Completed
Pomalidomide for Kaposi Sarcoma in People With or Without HIV
Phase 1/2 Completed
28 enrolled 23 charts
Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
Phase 1/2 Completed
38 enrolled 11 charts
A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
Phase 1 Completed
36 enrolled
A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma
Phase 2 Completed
48 enrolled
A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
Phase 1 Completed
48 enrolled
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
Phase 1 Completed
24 enrolled
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
Phase 1 Completed
24 enrolled
Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma
Phase 2 Completed
60 enrolled
A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
Phase 1 Completed
56 enrolled
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
Phase 1 Completed
18 enrolled
The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma
Phase 2 Completed
90 enrolled
A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
Phase 1 Completed
72 enrolled
A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
Phase 1 Completed
48 enrolled
Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy
Phase 2 Completed
41 enrolled
Risk Factors for Non-HIV-Related Kaposi s Sarcoma
Completed
1,383 enrolled
Development of Serologic Assays for Human Herpes Virus-8
Completed
394 enrolled
Tocilizumab for KSHV-Associated Multicentric Castleman Disease
Phase 2 Completed
8 enrolled 18 charts
Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions
Completed
29 enrolled 11 charts
Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma
Completed
24 enrolled
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Phase 1/2 Completed
78 enrolled 11 charts
Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
Phase 2 Completed
16 enrolled 13 charts
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Phase 1 Completed
24 enrolled
Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
Phase 2 Completed
19 enrolled 10 charts
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers
Completed
24 enrolled
Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection
Phase 2 Completed
Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma
Phase 2 Completed
24 enrolled
Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Phase 2 Completed
Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma
Phase 2 Completed
30 enrolled
BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
Phase 1/2 Completed
59 enrolled
Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
Phase 2 Completed
120 enrolled
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
75 enrolled
A Study of Patients With AIDS Syndrome
Completed
5,000 enrolled
Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens
Completed
2,000 enrolled
Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States
Completed
20,169 enrolled
Twins Study of Gene Therapy for HIV Infection
Phase 1 Completed
48 enrolled